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The processes governing lymphocyte fate (division, differentiation, and death), are
typically assumed to be independent of cell age. This assumption has been challenged
by a series of elegant studies which clearly show that, for murine cells in vitro, lymphocyte
fate is age-dependent and that younger cells (i.e., cells which have recently divided) are
less likely to divide or die. Here we investigate whether the same rules determine human T
cell fate in vivo. We combined data from in vivo stable isotope labeling in healthy humans
with stochastic, agent-based mathematical modeling. We show firstly that the choice
of model paradigm has a large impact on parameter estimates obtained using stable
isotope labeling i.e., different models fitted to the same data can yield very different
estimates of T cell lifespan. Secondly, we found no evidence in humans in vivo to support
the model in which younger T cells are less likely to divide or die. This age-dependent
model never provided the best description of isotope labeling; this was true for naïve
and memory, CD4+ and CD8+ T cells. Furthermore, this age-dependent model also
failed to predict an independent data set in which the link between division and death
was explored using Annexin V and deuterated glucose. In contrast, the age-independent
model provided the best description of both naïve and memory T cell dynamics and was
also able to predict the independent dataset.
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INTRODUCTION
The relationship between cell division, differentiation, and death is key to many processes in
adaptive immunity. Nowhere is this more fundamental to the immune response than in the case
of lymphocyte populations, which mount rapid, dramatic expansions and contractions following
pathogen challenge; generating both short-lived effectors and long-term memory populations,
within the overall context of decades-long lymphocyte homeostasis. Mathematical models of
lymphocyte dynamics typically assume that the processes that determine a lymphocyte’s fate
(division, differentiation, death) are stochastic and independent of the cell’s age (1–7); where cell
age is defined as the time since the cell arose from mitosis (Box 1). That is, the instantaneous
probability of an event is constant and independent of age, hence the probability of a cell dying
in the next hour is the same for a “newborn” cell as it is for a 20 year-old cell (provided they are
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BOX 1 | De nition of terms.
Age of a cell Time since cell was created by division (“born”) i.e.,
mitosis results in two daughter cells both of age 0
days
Lifespan of a cell Time from creation of a cell by division to its loss by
division, death or differentiation
Age-independent
fate
The probability of a cell’s death, differentiation or
division is independent of its age
Birth of a cell Creation of a cell by division of the mother cell
drawn from the same population). Recently, the validity of the
age-independent model has been challenged. In a series of elegant
studies from the Hodgkin group (8–10), both population level
and single cell analysis were used to investigate the interplay
between lymphocyte fates. This was formulated into a conceptual
age-dependent framework known as the “cyton” model (11). The
central rules of the cyton model are that independent stochastic
machinery governs cell processes (e.g., division, differentiation,
death), that these processes are competitive and that this
machinery is reset upon cell divisionwith (to first approximation)
no inheritance of lifespan. Thus, if a cell reaches its given time
to divide before it reaches its time to die, its progeny will be
preserved and indeed expand, whereas, if the converse applies,
the cell’s progeny will not survive. It is argued that variance
in the timing of these events underlies essential features of
the adaptive immune response such as rapid expansion or the
decision between tolerance and activation. The cyton model has
a number of distinct features. In particular cells have an intrinsic
“age” which is reset on division; cells that have recently divided
are therefore “younger” and have longer to live on average than
cells which have not divided recently.
An alternative age-dependent framework, which we refer to as
the “risk” model, has also been considered in the literature (12).
According to the risk model, cells which have recently divided
are more, not less, likely to die (13). For T lymphocytes the
link between cell activation and cell death, activation-induced
cell death, is well-recognized, but its contribution to steady state
lymphocyte homeostasis is less clear (14).
Which of these three paradigms (age-independent, cyton
or risk) best describes lymphocyte fate is unknown. Age-
independence, embodied in the exponential distribution
(Supplementary Figure S1), is frequently assumed. At least
part of its popularity is due to mathematical convenience: it is
a minimal assumption model in which cellular behavior can
be described by a single parameter represented as a rate in
ordinary differential equations. However, its popularity is not
just attributable to mathematical convenience, there is also a
large body of data consistent with exponential survival or growth.
Labeled lymphocytes in mice and humans disappear with an
apparently constant probability in vivo (3, 15–17) and CD4+ T
cell reconstitution following highly active antiretroviral therapy
in HIV-1 infection appears to be exponential (18, 19). However,
the age-independent model fails to explain a number of in
vitro observations. Firstly, close examination of the time-to-die
of naïve B cells shows an initial lag followed by an increasing
rate of death, consistent with an age-dependent probability
of dying. When IL-4 is added, the time to die of the entire
population shifts; consistent with a change in the mean of a
lognormally distributed time to die rather than a change in the
mean of exponentially distributed times to die (10). Secondly,
the addition of anti-CD3 to naïve CD4+ T cells shifts the time
at which the cells enter their first division, consistent with a
lognormally distributed time to first division (20). Thirdly,
there is evidence for competition between cell death and cell
proliferation as stimulation of naïve B cells with anti-CD40 and
IL-4 had no impact on the loss rate of cells until the time at
which surviving cells started to divide (10, 20). The same pattern
has been reported for T cells stimulated with αCD3 (20); again
this is not consistent with constant probabilities of proliferation
and death. Finally, the cyton model produced good fits to
both population level and single cell data from CFSE-stained,
stimulated B and T cells (10, 11, 21).
These in vitro observations support an age-dependent cyton
model in which recently divided cells have a reduced risk of death.
Furthermore, the authors argue that the cyton model cannot be
ruled out by the observation of exponential growth and survival
curves since, for certain parameter combinations, age-dependent
lognormally distributed times-to-proliferate and times-to-die
generate growth and survival curves that are practically
indistinguishable from exponential for most experimental set ups
(22). The authors even describe parameter combinations for a
single lognormal such that the resulting survival curve appeared
biphasic—a common property of many data sets, typically taken
as evidence for multiple (age-independent) subpopulations with
different kinetic behavior (7, 12, 23). Consequently, appearance
of exponential survival or growth is not sufficient evidence to
rule out age-dependent processes. Hodgkin et al. have recently
extended the cyton model by identifying the mechanism that
controls the duration of the clonal burst undergone by B and T
cells in vitro upon stimulation (24, 25). In the original version
of the cyton model the duration of the proliferative burst (but
not the proliferation rate) was inherited between generations
but the underlying mechanism was unknown. Analysis of T
and B lymphocytes post-stimulation under different conditions
revealed that Myc expression levels were approximately the same
in all cells upon the termination of the clonal burst, suggesting
that Myc levels need to surpass a certain threshold for cell
division to occur. Myc expression rates and consequently the
duration of the proliferative burst (but again not the proliferation
rates) were shown to be inherited with each division. This work
supports and extends the cyton model.
In short, there is very good evidence to support the age-
dependent cyton model of cell fate for both B and T lymphocytes.
However, in order to have a system that can be finelymanipulated
and readily observed, work to date supporting the cyton model
has been conducted almost entirely in murine cells in vitro. The
one exception which we are aware of is an in vivo analysis of
T cells in LCMV-infected mice [Supplementary Information in
(10)]. However, in this work only bulk cell populations were
studied, the analysis was restricted tomice and competingmodels
were not considered. It therefore remains an open question
whether the cyton model, risk model or age-independent model
governs lymphocyte fate in humans in vivo.
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Which model determines lymphocyte fate in vivo is a
fundamental question with a number of consequences. Firstly,
the assumption that lymphocytes are “age-less” underpins
the interpretation of many experiments including labeling
with stable isotopes, CFSE and BrdU as well as in vivo
killing assays (4, 26–28). Changing this assumption could
affect both the dynamic parameters estimated as well as
the biological interpretation of the results (29). Given the
ubiquitous application of these techniques (including the study
of T cell depletion in HIV-1-infected individuals, T regulatory
cell lifespan, T cell origin, cell dynamics in leukemia and
diabetes) changes to their interpretation could have widespread
impact (25). Secondly, immunity is a dynamic process.
Understanding how lymphocytes quantitatively regulate their
decision-making processes is essential for understanding basic
lymphocyte biology.
Here we investigate the rules determining the fate of T
lymphocytes in humans in vivo during healthy homeostasis.
We consider CD4+ and CD8+ naïve and memory T cells
and focus on two fates: death and division. Our approach is
to combine stable isotope labeling in vivo (both with heavy
water and deuterated glucose), Annexin V staining ex vivo and
mathematical modeling. We aim to determine: (i) whether the
choice of model makes a significant difference to estimates of
parameters describing lymphocyte kinetics, (ii) which model best
describes heavy water labeling patterns in naïve and memory T
cells, and (iii) which model best predicts a new dataset which
quantifies the relationship between short-term in vivo labeling
with deuterated glucose andAnnexin V binding as an indicator of
incipient death. In this way we set out to elucidate the patterns of
division and death which underlie normal lymphocyte behavior
in vivo.
RESULTS
Impact of Model Paradigm on Estimates of
Lymphocyte Kinetics in vivo
Stable isotope labeling is an established technique for quantifying
cell dynamics (5, 30, 31). Briefly, subjects are given deuterium
in the form of deuterated glucose or heavy water. Deuterium
is incorporated into the DNA of cells when they divide and
lost when labeled cells die or differentiate. Cells of interest are
sampled and the level of deuterium incorporated into their DNA
is quantified by mass spectrometry. The rate of cell proliferation
and the rate of cell disappearance are estimated by fitting a
mathematical model to the labeling data and finding the values
of the rates which minimize the discrepancy between data and
prediction. The mathematical models used to interpret stable
isotope labeling data typically assume that cells proliferate and
die/differentiate in an age-independent manner (3, 5, 7, 23, 32–
37). To investigate the extent to which estimates of proliferation
would change if the age-independent assumption was relaxed,
we developed an agent-based model (ABM) of a population of
cells in homeostasis (Methods). The ABM simulated the labeling
and delabeling phases of a deuterium labeling experiment,
modeling division and disappearance events according to each
of the paradigms of cell fate. In the ABM, cells were initialized
upon birth (mitosis) with times to divide and to disappear
drawn from a gamma or lognormal distribution. We investigated
three paradigms:
i. the cyton model, in which the probability of a cell dying or
dividing increases with its age;
ii. the risk model, in which the probability of death or division
decrease as the cell ages;
iii. the age-independent model, in which the probability of death
or division is independent of cell age.
The parameters of the distribution determine which paradigm
the simulated population obeys (Supplementary Figure S1).
When the distribution is exponential (gamma with rate = 1)
then the probability of an event (conditioned on survival to that
point) is independent of age and the age-independent model is
captured. When the distribution is gamma with shape parameter
lower than one then the distribution of time to an event has a
zero mode and a steeper slope than the exponential distribution
and the probability of an event decreases with age, i.e., the risk
paradigm is captured. When the distribution is gamma with
a shape parameter higher than one then the mode is greater
than zero, probability of an event increases with age and the
cyton paradigm is captured. For the lognormal distribution, the
mapping between the parameters and paradigms is less precise
but when the location parameter is large relative to the scale
then the distribution is strongly right-skewed and the mode is
much greater than zero (cells much less likely to die or divide
immediately after a previous division event) and the cell behavior
conforms to the cyton paradigm; as the location parameter
decreases relative to the scale then the mode decreases and the
behavior becomes risk-like. We reiterate that we define the age of
a cell as the time since creation of the cell by mitosis (Box 1).
We considered both a homogeneous cell population and
a heterogeneous population consisting of two subpopulations.
Under the heterogeneous scenario, both subpopulations were
governed by the same form of distribution (i.e., two exponentials,
two gammas or two lognormals) with varying parameters. We
thus had 6 models (Table 1): two (Model 1 and 2) were age-
independent, the remaining four were age-dependent models
with Models 3 and 4 obeying the cyton paradigm and models
5 and 6 the risk paradigm. For the cyton and risk models we
considered the populations to be governed either by gamma or
lognormal distributions; for brevity we focus on results from
the gamma distribution in the text; results obtained with the
lognormal distribution are similar unless stated otherwise and are
presented in the figures and Supplementary Information.
These models, representing the three paradigms, were fitted to
experimental data from a published stable isotope-labeling study
(32). In this study, 5 healthy human volunteers were given heavy
water (2H2O) for 63 days and the fraction of label incorporated in
the DNA of naïve (CD27−CD45RO−) and memory (CD45RO+)
CD4+ and CD8+ T cells was measured at successive time points.
Naïve CD4+ and CD8+ T Cells
We found that the homogeneous population models consistently
provided a better description of the naïve cell labeling data
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TABLE 1 | Summary of the different models considered.
Model Paradigm Number of subpopulations Distribution of time to die and divide Number of free parameters
Age-independent, homogeneous Age-independent 1 Exponential (gamma with shape = 1) 1
Age-independent, heterogeneous Age-dependent 2 Exponential (gamma with shape = 1) 3
Cyton, homogeneous Cyton 1 Gamma or lognormal 2
Cyton, heterogeneous Cyton 2 Gamma or lognormal 5
Risk, homogeneous Risk 1 Gamma or lognormal 2
Risk, heterogeneous Risk 2 Gamma or lognormal 5
The number of kinetically distinct subpopulations, type of distribution for times to die/differentiate and to divide, and number of free parameters for each of the 6 models. We considered
3 paradigms (age-independent, cyton, risk); 6 models (i.e., homogeneous and heterogeneous versions of each paradigm) with 10 formulations in total (as each of the age-dependent
models can be described either by the gamma or the lognormal distribution).
than heterogeneous population models, in agreement with the
literature (7, 12). So, when considering the impact of model
choice on parameter estimates, we restrict ourselves to the
homogeneous versions of the three paradigms (age-independent,
cyton, and risk). The median lifespan (time to death or division)
estimated from the three models are shown in Figure 1; the
distribution of lifespans are shown in Supplementary Figure S2.
The age-dependent cyton model gave the longest estimates
of naïve cell lifespans; they were systematically greater than
lifespans obtained using the age-independent model (P = 0.002,
mean difference= 366 days, 49% increase, Wilcoxon signed rank
two-tailed) and even longer than lifespans obtained using the risk
model (P = 0.002, mean difference = 465 days, 72% increase).
The lognormal version of the cyton model gave similar results
to the version based on the gamma distribution described above
whilst the lognormal version of the risk model failed to fit the
experimental data.
Memory CD4+ and CD8+ T Cells
Previous studies assuming age-independent models of
lymphocyte dynamics have suggested that memory cell pools
are kinetically heterogeneous—at least two exponentials being
required to capture their dynamics (7, 38, 39). However, Dowling
et al. (22) have shown that, for certain parameter combinations,
the lognormal distribution results in biphasic survival curves
which could be mistaken for the signature of a heterogeneous
population, when age-dependence is not taken into account.
Therefore, we do not make any assumption about whether
the memory T cell populations are kinetically homogeneous
or heterogeneous.
The estimated median lifespans are presented in Figure 1, the
lifespan distributions are given in Supplementary Figure S3. In
all cases the heterogeneous version of a model yielded longer
lifespans than the corresponding homogeneous version (P= 2×
10−9, mean difference = 212 days, 105% increase). Within both
the homogeneous and heterogeneous models we saw the same
ranking of lifespans as for naïve cells i.e., the cytonmodel gave the
longest lifespans, followed by the age-independent model with
the risk model giving the shortest lifespans. If the cyton model
described by the lognormal distribution is mistakenly identified
as heterogeneous age-independent, as suggested (22), then this
would result in a significant overestimate of median lifespan
(P = 0.002, mean difference in lifespan homogeneous cyton v
heterogeneous age-independent= 298 days, 360% increase).
We conclude that assumptions about the underlying paradigm
can have considerable impact on estimates of lymphocyte lifespan
calculated from stable isotope labeling data.
Which Paradigm Provides the Best
Description of Stable Isotope Labeling
Data?
Naïve CD4+ and CD8+ T Cells
In order to determine which paradigm provides the best
description of T cell fate we fitted the different models to
the stable isotope labeling data described above and compared
the quality of the fit using the Corrected Akaike Information
Criterion [AICc (40), Methods]. For naïve CD4+ and CD8+
T cells, the homogeneous age-independent model provided
a better description of the experimental data than either
the homogeneous cyton or the homogeneous risk models in
10/10 cases (Figure 2, AICc for the age-independent model
significantly lower than the best fitting age-dependent model P
= 0.002, two tailed Wilcoxon, lower AICc indicating a better
description) but the median difference in AICc was small (2.7).
The heterogeneous cyton and risk models were not competitive
(lose in 10/10 cases, P = 0.002) and the median difference in
AICcs was large (19.5). The heterogeneous models failed because
they have a larger number of parameters but do not offer a better
fit than the homogeneous models (Supplementary Figure S4,
Supplementary Table S1). In summary, for naïve CD4+ and
CD8+ T cells, the data (i) support a homogeneous model rather
than a heterogeneous model and (ii) provide no evidence to
support age-dependence.
Memory CD4+ and CD8+ T Cells
Despite the fact that we considered 4 times more age–dependent
than age–independent models (risk and cyton; lognormal and
gamma formulations) the age-independent models provided the
best description of the memory T cell data in 7/10 cases. Where
data was dense the heterogeneous version of the age-independent
model was successful (5/10 cases); where data was limited the
homogeneous age-independent model was preferred (Figure 2).
The homogeneous risk model (lognormal distribution) was
better in the remaining three cases, but by small differences
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FIGURE 1 | Impact of model assumptions on lifespan estimates. Median lifespan estimates obtained by fitting models with different assumptions about cell fate to
heavy water labeling data (32). Top row: naïve T cells, bottom row: memory T cells. Each line and symbol corresponds to a different subject (A–E). Here the cyton and
risk models are described using the gamma distribution, similar results are obtained using the lognormal distribution. We use the color scheme age-independent:
aqua, cyton: cobalt, risk: red. The lifespan of a cell is defined as the time to first event (division or death).
in the AICc (mean 2.1, Supplementary Table S2). The cyton
model (in either heterogeneous or homogeneous form) was never
competitive; losing in 10/10 cases (mean difference in AICc
between cyton and winning model: 22.1). The plots of the fits
for Memory CD4+ and CD8+ T cells are shown in Figure 3. In
summary, the dynamics of CD4+ and CD8+ T cell memory cells
in vivo are best described by age-independent models; the cyton
model performs poorly.
Approach Validation
It is noticeable that, when comparing the fit of the different
paradigms to the experimental data, many models produce a
similar fit and that the age-independent model therefore tends
to win because it has fewer parameters. We were concerned
that this approach may be biased against the more complicated
models because the data may not be sufficiently dense to identify
the age-dependent models. We therefore investigated whether
age-dependent models, if they were true, would be expected
to generate sufficient signal in these types of data sets to be
identified. We generated in silico datasets of different sizes (with
noise) consistent with a known paradigm and then investigated if
our approach could correctly identify the generating paradigm
(Methods). We found that when the generating model was
the cyton model (either lognormal or gamma) the generating
model was always correctly identified and (with the exception
of one model for the smallest dataset n=6) no other model
came within 6 AICc of the generating model (Figure 4A).
When the generating model was risk, for the lognormal version
the generating model was always correctly identified; for the
gamma version the generating model was correctly identified the
majority of the time and when it was not the winning model
it was always within 1 AICc of the winning model i.e., it was
indistinguishable from the winning model (Figure 4B). When
the generating model was the age-independent heterogeneous
model then the winning model was the generating model for n
≥ 11, though for n = 11 (but not higher) other models were
competitive. For the age-independent homogeneous model then
the winning model was, unexpectedly, gamma risk and this
did not improve even for very large data sets (Figure 4C). On
investigating this further, we found that the winning version of
the gamma risk model always had shape parameter close to 1
(mean 0.97) i.e., the winning model was very close to the age-
independent exponential but the additional freedom to slightly
decrease the shape parameter resulted in an improved fit. Of
note, there was never a case when data generated by any age-
dependent paradigm was misclassified as age-independent. In
summary, the approach performs well but has a slight bias
against the age-independent model; it robustly identified the
cyton model whenever it was the generating model. We conclude
that the age-dependent models should be distinguishable from
age-independent models with this type and density of data
and that it is unlikely that cell dynamics consistent with the
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FIGURE 2 | Median normalized AICc for the fit of each of the models to data from naïve and memory CD4+ and CD8+ T cells. The model with the lowest AICc is the
best performing model. The age-independent model performs best both for naïve CD4+ and CD8+ T cells (homogeneous version) and for memory CD4+ and CD8+
T cells (heterogeneous version). The data fitted is from the heavy water study. (A) shows median normalized AICc for the gamma versions of the age-dependent
models; (B) shows median normalized AICc for the lognormal versions of the age-dependent models. The individual AICc values are in Supplementary Tables S1,
S2. We use the color scheme age-independent: aqua, cyton: cobalt, risk: red; solid color in bars denotes CD4+ cells, hatched color denotes CD8+ cells. Note the y
axis scales are different in each panel (and broken in one panel). Absolute value of the AICc does not carry any meaning so we plot the normalized AICc which is the
difference between the AICc of the model being investigated and the winning model (the normalized AICc is therefore zero for the winning model).
cyton model would be misidentified as coming from an age-
independent model.
Alternative Approach
We have shown that fitting the models to the experimental
data and comparing their AICcs provides support for the age-
independent family of models. Furthermore, in silico testing
indicated that this approach performs well. Nevertheless, we were
still concerned that this approach suffers from a dependence
on the number of data points relative to model complexity;
we therefore implemented an alternative method. In the
previous approach (above) we compared models on the basis
of their AICcs by restricting parameter ranges such that the
distributions obeyed either the age-independent, risk or the
cyton paradigm. For the alternative approach, we took advantage
of the fact that a single gamma distribution can describe
all three paradigms. We allowed parameters to vary freely,
effectively ranging over all paradigms, and then investigated
which paradigm the best fit parameters corresponded to. In this
way all models were considered equally without reference to
model complexity. We reiterate that, for the gamma distribution
a shape parameter <1 corresponds to the risk paradigm, a
shape parameter equal to 1 corresponds to the age-independent
paradigm and a shape parameter >1 corresponds to the
cyton paradigm.
For naïve T cells the shape parameter was poorly identifiable;
in most cases the CI included 1 (i.e., shape parameter not
significantly different from one). For memory T cells the shape
parameter could be estimatedmore accurately and in all cases was
very close to one (Figure 5). These results closely mirror those
obtained using the AICc. That is, for naïve T cells it is difficult
to distinguish between paradigms but there is no clear support
for the cyton model. Whilst for memory T cells, the dynamics are
best described by the age-independent paradigm.
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FIGURE 3 | Best fit of the 6 models to Memory CD8+ and CD4+ T cell data. A different subject (A-E) is shown in each panel. Here the cyton and risk models are
described using the gamma distribution; similar results are obtained using the lognormal distribution. We use the color scheme age-independent: aqua, cyton: cobalt,
risk: red; solid lines denote best fit of homogeneous models, dashed lines best fit of heterogeneous models; black circles denote experimental data. (A) Depicts
memory CD4+ T cells. (B) Depicts memory CD8+ T cells. Data taken from Vrisekoop et al. (32).
We wished to extend this alternative approach to investigate
the lognormal family of distributions. The problem arises that
for the lognormal distribution, unlike the gamma distribution,
there are no parameter combinations such that the lognormal
distribution is age-independent, nor is there a precise mapping
between parameter combinations and the age-dependent
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FIGURE 4 | Approach Validation. In silico data (with noise) was generated using the paradigm named above each panel. Datasets of different sizes (n = 6, n = 11, n
= 20, n = 30, n = 50) were constructed; n = 11 corresponds to the typical size of experimental data set analyzed in the previous section. We then used our approach
to identify the generating model. Briefly, each of the models was fitted to the data and the normalized AICc is plotted. The normalized AICc for the winning model
(which is zero by definition) is plotted as 0.01 since log10(0) is not defined. In each panel a different model was used to generate the data (generating model is named
above each panel), each line represents the normalized AICc from fitting a different model to the generated data, the x axis is the size of the data set; the AICc of the
generating model is indicated by a black arrow. The model with the lowest normalized AICc is the model identified as the generating model by our approach. (A)
Generating model is the cyton model (either lognormal or gamma). The generating model was always correctly identified (lowest AICc) and, with the exception of one
model for the smallest dataset (n = 6), no other model came within 6 AICc of the generating model (B) Generating model is the risk model. For the lognormal version
the generating model was always correctly identified; for the gamma version the generating model was correctly identified the majority of the time and when it was not
the winning model it was always within 1 AICc of the winning model (i.e., it was indistinguishable from the winning model). (C) Generating model is the
age-independent model. For the age-independent heterogeneous model the winning model was the generating model for n ≥ 11, though for n = 11 (but not higher)
other models were competitive. For the age-independent homogeneous model the winning model for most values of n was, unexpectedly, gamma risk. The gray
dashed horizontal lines correspond to a difference in AICc of 6 and 10, these are the rule of thumb cut-offs typically used with the AICc. A difference of 6 is considered
sufficient to support the winning model, a difference of 10 allows the favoring of the winning model with confidence.
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FIGURE 5 | Alternative approach: shape parameter of the best fit gamma distribution. We fitted a model in which time to death/differentiation and time to division
were drawn from gamma distributions with unconstrained shape and scale parameters. The model thus has the freedom to take up the risk paradigm (shape < 1), the
age-independent paradigm (shape = 1) or the cyton paradigm (shape > 1). The shape parameter of the best fit distributions to each of the cell populations is plotted
above. Vertical green dashed line corresponds to shape = 1. The first 10 estimates (above the horizontal line) are for naïve T cells, the next 10 estimates (below the
horizontal line) are for memory T cells.
paradigms. Instead we looked at the (instantaneous) probability
of death conditioned on survival to that point. If the underlying
paradigm is risk then we would expect a strong left skewed
distribution (i.e., cells more likely to die immediately after
division) whereas if the underlying paradigm is cyton-like
then then the probability of death would increase with time
(older cells more likely to die). We found that for naïve
T cells the distributions were rather poorly identified. For
memory T cells the picture was much clearer, for both a
homogenous and a heterogeneous lognormal model the
probability distributions were much more consistent with the
risk rather than the cyton paradigm (Supplementary Figure S5).
Age independent paradigms could not be considered for the
lognormal distributions within this framework but it is clear that
there is little support for the cyton model.
Measurement of Deuterated Glucose
Labeling in Annexin V–Positive and
–Negative Cells
A model’s ability to predict new data is as important, and
arguably a more stringent test, than its ability to fit existing data.
We therefore generated an independent dataset consisting of a
different type of data against which to assess the models. As we
were interested in the temporal link between division and death
we combined deuterated glucose pulse-labeling with separation
of cells during follow-up according to a marker of incipient
apoptosis, Annexin V binding. Annexin V is a protein which
binds to phosphatidylserines translocated to the outer membrane
during apoptosis; its binding on the cell surface is an early
indicator of apoptosis. In this way we explored the relationship
between recent division and risk of death.
Four healthy adults received deuterated glucose ([6,6-2H2]-
glucose) as an intravenous infusion for 24 h. Blood samples were
taken at successive time points post-infusion and CD4+ memory
(CD45RO+) T lymphocytes were sorted by flow cytometry
into Annexin V-positive and Annexin V-negative subsets and
deuterium incorporation into cellular DNA in each subset was
quantified (Figure 6A).
Prediction of Annexin V Labeling
Signatures
We wished to ascertain the ratios of Annexin V-positive and
-negative cells in labeled and unlabeled cell populations. This
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FIGURE 6 | Observed and predicted signatures in Annexin V data set. (A) Four subjects were labeled with deuterated glucose for 24 h. The fraction of labeled DNA in
Annexin V+ and Annexin V– CD4+CD45RO+ T cells was quantified (one subject per graph). (B) This was converted into a signature of the fraction of Annexin V+ cells
amongst labeled and unlabeled cells. (C) We tested the ability of each of the 6 models to predict this signature. The heterogeneous age-independent and both
homogeneous and heterogeneous risk models correctly predicted the signature; the homogeneous age-independent, homogeneous cyton and heterogeneous cyton
models did not.
cannot be measured directly, i.e., we cannot sort labeled and
unlabeled cells and then quantify Annexin V binding, as the
measurement of label requires the destruction of the cells (their
DNA is isolated and hydrolysed). Instead we calculate the ratio
at days 3 and 7 from the proportion of label in the Annexin
V-positive and -negative cells (Methods). This analysis revealed
a distinct signature in the experimental data (Figure 6B): the
fraction of Annexin V-binding cells in the labeled population
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was consistently higher than the fraction in the non-labeled
population at both days 3 and 7 (P= 0.008,Wilcoxon two tailed).
We investigated the ability of the 6 different models (Table 1) to
predict this signature.
For each model we took the best fit parameter combinations
generated in the previous section by fitting to heavy water
labeling of Memory CD4+ T cells, and then used these
parameters to predict the outcome of the Annexin V/deuterated
glucose experiment using the ABM. Apoptosis has been shown to
last for 12–24 h (41), and the translocation of phosphatidylserines
to the outer part of the membrane of the cell is known to
occur from an early stage of the process (42). Accordingly,
we approximated the fraction of Annexin V-binding cells in
labeled and non-labeled cell populations by the fraction of
simulated cells with remaining lifetimes lower than 24 h. We
then investigated the models’ ability to predict the observed
signatures. The fraction of Annexin V-binding cells ex vivo is
known to overestimate the fraction of cells dying in vivo by
at least 50-fold (43) [presumably because not all Annexin V-
binding cells die (44, 45) and because taking cells ex vivo increases
death (46)]; furthermore the individual subjects being simulated
are different from the individuals subjects fitted so we did not
aim to predict the absolute levels of label incorporation (which
shows considerable inter-individual variation). Instead we aimed
to predict the observed signature which was clear and consistent
across all four individuals (Figure 6B).
Of the six models considered, three successfully predicted
the observed signature. The heterogeneous age-independent, and
both the homogeneous and heterogeneous risk models correctly
predicted that the fraction of Annexin V+ cells was significantly
higher amongst labeled cells than non-labeled cells at day 3 and at
day 7 (Figure 6C). Intuitively, this makes sense: if the population
is heterogeneous age-independent then the subpopulation with
faster kinetics will be overrepresented amongst the labeled cells.
These cells die faster than the slow population labeled cells and
thus will express a higher proportion of Annexin V. Similarly,
under the risk paradigm, recently divided (i.e., labeled) cells will
have a greater risk of dying. The homogeneous age-independent
model and both homogeneous and heterogeneous versions of
the cyton model failed to predict the signature and were not
consistent with the experimental observations (Figure 6C).
DISCUSSION
T cell proliferation and death are typically assumed to be
independent of cell age (where age is defined as time since
division). However, it has been postulated that lymphocyte
division and death are governed by the age-dependent cyton
model and that this form of immune regulation permits rapid
induction of a wide range of responses from tolerance to strong
immunity on the basis of small changes in mean time to divide,
die or differentiate (10, 20). There is very strong evidence that
murine lymphocytes in vitro obey the cyton model (10, 11,
20, 21, 24). To investigate whether T lymphocytes in humans
in vivo also obey this age-dependent model, we combined
mathematical modeling, analysis of existing heavy water labeling
data and generation of new Annexin V and deuterated glucose
labeling data.
Our main conclusions are that firstly, the choice of model
paradigm has a large impact on estimates of cell lifespan
obtained using stable isotope labeling. It seems likely that
this conclusion will also apply to the interpretation of CFSE
and BrdU labeling data. Secondly, we found no evidence to
support the cyton model as a description of T cell dynamics
in humans in vivo. No version of the cyton model (neither
homogeneous nor heterogeneous, lognormal nor gamma) ever
provided the best description of in vivo heavy water labeling.
This was true for all four T cell populations considered: naïve
CD4+ T cells, naïve CD8+ T cells, memory CD4+ T cells
and memory CD8+ T cells. An alternative approach which
was independent of model complexity (fitting an unconstrained
gamma or lognormal distribution) also found no evidence for the
cyton model. Furthermore, the cyton model (all versions) also
failed to predict patterns in an independent, newly generated data
set. Thirdly, the age-independent exponential model provided
the best description of both naïve and memory T cell dynamics.
Age-independent models provided the best fit to naïve T cell
labeling data in 10/10 cases and to memory T cell labeling
data in 7/10 cases, though differences were not always large.
The age-independent model was also able to predict the novel
Annexin V dataset. Our finding in favor of an age-independent
paradigm is not inconsistent with the Hayflick limit. Age as
defined by telomere shortening is counted from haematopoiesis
and is distinct from, and on a different timescale to, the age
since division which we focus on. Additionally, the action of
telomerase, which is up-regulated in dividing lymphocytes (47),
may mean that most T cell death is independent of the Hayflick
limit. Time since haematopoiesis will be related to the age of the
individual subject, the association between age of the individual
and T cell dynamics has recently been studied in mice (48).
Given that the evidence for the cyton model in vitro is so
strong, it is surprising that it fails to explain lymphocyte dynamics
in vivo. There are at least three possible explanations. Firstly,
the difference may relate to the difference between conditions
in vitro and in vivo. In vivo, even if a cell’s intrinsic programme
is age-dependent, randomly encountered cell-exogenous stimuli
such as cytokines, cell-cell contact or antigen may render its
resultant behavior age-independent. That is, lymphocytes may
have an age but other factors dominate in vivo so in practice
age does not determine their fate (49). Of note, in many of
the in vitro experiments supporting the cyton model, autocrine
Il-2 is blocked (20, 24, 50). Specifically, in cultures of murine
T cells, murine IL-2 (mIL-2) is blocked by the addition of
an antibody and then the media supplemented with a fixed
concentration of human Il-2 which is active on murine T cells
but not blocked by the mIL-2-specific antibody. In this way the
natural effect of autocrine Il-2 is removed. This is one example
of a possible stimuli that would be present in vivo but has been
excluded in vitro and which could have a profound effect on T
cell behavior. Secondly, the difference may relate to differences
between mice and humans. Human andmurine immune systems
face different selection pressures and may have evolved different
behavior. For instance, there is evidence that the lifespan of
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memory and naïve T cells and the maintenance of naïve T
cell homeostasis are very different in humans and mice (15).
However, a study by Gossel et al. (39) which studied the dynamics
of memory CD4+ T cells in mice in vivo, also found that
Ki67+ (“young”) cells had lifespans that were indistinguishable
from Ki67− (“old”) cells providing strong support for an age-
independent model compared to age-independent alternatives in
mice in vivo. This agrees well with our conclusions in humans,
suggesting that the difference is more likely to relate to in
vitro v in vivo conditions rather than mice v humans. Finally,
the difference may relate to differences in stimulation. In the
scenarios we modeled there was no overt infection, whilst in
the work supporting the cyton model, lymphocytes were always
stimulated exogenously. Since the individuals we studied did not
have any symptomatic infection we did not simulate the “division
destiny” of lymphocytes (duration of the division burst of B and
T cells after stimulated in vitro) which is a feature of the cyton
model (10, 24). It would be interesting to repeat our work in
individuals with ongoing infection to see if the rules of cell fate
were altered. Nevertheless, the authors of the cyton work have
always argued that the cyton paradigm also explains lymphocytes
in homeostasis (10) and have investigated the consequences of
the cyton paradigm in homeostasis upon thymus involution and
aging (51, 52).
A potential concern about our approach is the use of the
AICc for comparing models. Although such an approach is an
appropriate, accepted technique (40) and is widely used formodel
selection e.g., (53, 54) it does identify the minimal model needed
to describe the data rather than the “true” model. For naïve T
cells, all the models fitted the data in a very similar way and
so the winning model is necessarily the model with the least
number of parameters i.e., the age-independent homogeneous
model. For this reason our conclusion for the naïve cells is simply
that there is no evidence to support age-dependence. However,
for memory T cells, age-independent models consistently out-
perform age-dependent models despite not having consistent
differences in complexity. The winning model in most cases
(age-independent heterogeneous) is more complicated than the
cyton model (3 parameters for age-independent compared with
2 for cyton). When data becomes sparse (some people missed
some sampling time points) and there is insufficient data to
support the heterogeneous age-independent model, the winning
model jumps to the homogeneous age-independent model (1
parameter) rather than any of the age-dependent options which
have intermediate complexity. These conclusions were supported
by a number of additional pieces of work. Firstly, in silico
simulations suggests that our approach is unlikely to incorrectly
favor an age-independent model if the generating model is
actually the cyton model; if anything the approach is biased
against age-independence. Secondly, when using a model with
the same number of parameters for the age-independent, cyton
and risk model (i.e., gamma distribution with unconstrained
parameters) then for memory cells the age-independent model
was strongly favored. Finally, our conclusions are supported by
predictions of a new independent data set.
All the models considered contain a number of simplifying
assumptions. This is essential to avoid over parameterization but
has the potential to affect our results. Firstly, we assume that
there is no inheritance of times to die or to divide between
subsequent generations of cells. To a first approximation this
is true; even in the earlier studies of cell fate where detailed
in vitro measurements were made there was no evidence to
support inheritance (10, 20, 22, 55). However, very fine single
cell fate mapping has revealed signals for complex inheritance
between cousins (21). Secondly, we neglect cell flow into the cell
populations. We have shown in humans (34) and others have
shown in mice (39) that such constitutive flow is ongoing even
in homeostasis. Finally, we have assumed that both death and
division of a given population can be described by the same
probability density function (same parameters). The impact of
these various assumptions cannot be directly explored due to
the number of additional, correlated parameters which would
need to be introduced. For instance, to investigate the third
point above, we relaxed the assumption that death and division
were described by the same distribution and considered two
additional homogeneous age-dependent models of cell fate,
in which division and death mechanisms were expressed by
different probability density functions of the same form (gamma
or lognormal). These models never outperformed the other
versions in any of the cases but this is most likely due to
the excess complexity of the new models (i.e., the data are
not sufficiently rich to support the more complex models).
Although it is not possible to explicitly analyze these simplifying
assumptions we note that they have been applied to all paradigms
equally. Finally, all participants were aged under 35 years. We
therefore cannot determine whether the rules of cell fate in older
individuals are best described by a cell age-dependent or cell age
independent model.
In general, the work that can be performed in humans is
very limited compared to what can be achieved with murine
cells in vitro. We are restricted to studying population averages
rather than single cells and must rely on natural physiology
rather than use knockouts or transfectants. Nevertheless, the
different paradigms do predict distinct patterns of behavior that
can be detected at the cell population level in the absence
of manipulation enabling us to distinguish between them. In
summary, the cyton model provides a compelling hypothesis
to explain how the immune system interleaves lymphocyte fate
to achieve a robust, diverse response; it is strongly supported
by in vitro work using murine cells. Unexpectedly, using three
different approaches, we find no evidence that it describes T
cell fate in healthy humans in vivo. Additionally, we show that
extreme care needs to be taken in selecting models for estimating
lymphocyte dynamic parameters as the choice of the underlying
paradigm can have a profound impact on the estimates derived.
Given the strength of the evidence for the cyton model in vitro
we suggest that age probably determines cell fate in vitro but
in vivo, where cells receive a huge number of external stimuli
from other cells, antigen and cytokines, extrinsic factors rather
than age are more likely to determine cell fate. A useful analogy
is human lifespan. Fundamentally, the time when a human dies
depends on their age and, in the developed world in peacetime,
this pattern is manifest and age is a major determinant of the
probability of death. However, during wartime, death is largely
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a random event and time of death is independent of a person’s
age. We suggest that the cyton model describes the fundamental
rule of cell fate and is manifest “in peacetime” (in vitro) but in
war (in vivo) these effects are overridden by the large number of
cell-exogenous stimuli.
The age-independent exponential distribution is usually
assumed but rarely justified. Here, we show that, in vivo
for memory and naïve CD4+ and CD8+ T cells in healthy
humans, the age-independent model appears to provide the best
description of cell fate in homeostasis.
MATERIALS AND METHODS
Agent-Based Model
We developed an agent-based model (ABM) to simulate stable
isotope labeling of a population of cells in homeostasis. Upon
birth (by division of the mother cell), cells were assigned times to
die/differentiate and to divide which were drawn from a defined
distribution (gamma or lognormal). The time step in the model is
1 day. After each time step, the age of the cell is increased by 1 day.
If the age becomes equal to the time to die/differentiate, the cell
is removed from the population. If it reaches its time to divide,
it is substituted by two new daughter cells of age 0 with times to
die/differentiate and to divide which are drawn again from the
defined distribution. The model was implemented in C++.
Kinetic Heterogeneity
We allow for both kinetically homogeneous and heterogeneous
populations. In a heterogeneous configuration, each
subpopulation is assigned a different distribution of times
to die/differentiate and times to divide. For a population
consisting of n subpopulations, n-1 ratios are required to
specify the proportions at which each of them is found. Each
subpopulation is assumed to be independently in homeostasis,
and the progeny of a given cell belong to the same subpopulation
as the mother cell (i.e., its times to an event are drawn from the
same distribution).
Deuterium Labeling Process
We simulate both heavy water and deuterated glucose labeling
experiments. During the labeling period τ , each time that a cell
divides, it is replaced by two daughter cells that are labeled in
proportion to the label availability. In the case of heavy water,
the availability of label is described by the following empirical
equation (32):
U(t) = f (1− e−δt)+ βe−δt during label intake τ ≤ t
U(t) = [f (1− e−δτ )+ βe−δτ ] e−δ(t−τ ) after label intake t > τ
In the case of deuterated glucose, because of the fast turnover
rate of glucose, availability of label is assumed to follow a square
pulse (17):
U(t) = U during label intake t ≤ τ
U(t) = 0 after label intake t > τ
The parameters (f, δ, β, U) were estimated by fitting to
successive measurements of label availability in plasma in the
case of deuterated glucose or urine in the case of heavy water
(Supplementary Table S4).
Model Initialization
In the ABM the remaining lifetime of the population will
evolve in time as the population ages. Since we were
studying adults, we assumed the cell population had
reached steady state. We therefore initialize the times to
die/differentiate and to divide in the ABM, from the steady state
distributions of remaining lifetime which we derived analytically
(Supplementary Information).
Fitting the Model
The fitting of the ABM to the experimental data with an ordinary
least squares objective function was carried out using the global
optimization algorithm pseudoOptim from the FME package in
R (56). To minimize stochasticity, 5 different random seeds were
considered each time a labeling curve was generated in C++ and
the median of the 5 costs used. The number of free parameters
depended on the model assumed (Table 1).
Age-Independent, Cyton, and Risk Paradigms
The three paradigms are captured by non-overlapping parameter
spaces of the gammas and lognormal distributions of times
to die/differentiate and to divide. The parameter ranges of
the fitting procedures were configured accordingly for each
case. For the gamma distribution, shape parameters equal to
one (exponential distribution) are characteristic of an age-
independent population; shape parameters lower than one (zero
mode) are characteristic of the risk model; and shape parameters
higher than one (higher than zero mode) are representative of
the cyton model. For the lognormal distribution, we imposed
the restriction that distribution modes had to be higher than 7
days, or lower than 2, respectively. The upper bound on the scale
of the lognormal was set to 2.5; this was sufficient to observe
dramatic risk behavior. Increasing the scale parameter to a value
of 3 improved the fits of the homogeneous age-dependent risk
model with one lognormal (not enough to change the results),
but resulted in lifetimes which were unrealistic (in many cases,
more than 25% of the population died or divided in the first 24 h.
after division), Supplementary Table S3. Extending these limits
further resulted in unfeasible fitting times due to the integration
routines in the ABM. Additional details regarding the ABM are
included in the Supplementary Information. Examples of the
relationship between the distributions of time to die/differentiate
and divide and the age-dependence of probabilities are provided
in Supplementary Figure S1.
Corrected Akaike Information Criterion
(AICc)
We use the AICc metric to compare different models (40). The
AICc introduces a penalty for the number of parameters and a
correction for small sample size:
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where ssr is the sum of squared residuals, k is the number of
estimated parameters and n is the number of data points. The
best model is identified by the lowest AICc. A frequently used
rule of thumb states that an AICc difference < 2 is not sufficient
to empirically support the winning model; that a difference of 6
is considered as sufficient; and that a difference >10 favors one
model with confidence (40). The absolute value of the AICc is not
meaningful so we report the normalized AICc which is defined
as the difference between the AICc and the AICc of the winning
model (and is therefore zero for the winning model).
Approach Validation
To investigate whether the approach of fitting the different
models to the data and selecting the model with the lowest AICs
yielded the correct model (i.e., the model which generated the
data) we performed the following study. For each of the six
models considered (homogeneous exponential, heterogeneous
exponential, homogeneous gamma cyton, homogeneous gamma
risk, homogeneous lognormal risk and homogeneous lognormal
cyton) we simulated data. Specifically, we first simulated data
from the model using realistic parameters (parameters were
chosen based on fits to the heavy water data from the previous
section), added noise to each data point [random variables
sampled from N(0, 0.025)] and selected datasets of varying size
(n = 6, n = 11, n = 20, n = 30, n = 50). For the n = 11
simulated data we chose timepoints which coincided exactly with
our experimental time points; n = 6 is a subset of these and n
> 11 an extension of these. We then fitted each of the 6 models
to each of these 5× 6= 30 datasets and calculated the AICc. We
then analyzed whether the winningmodel (model with the lowest
AICc) was the model which was known to generate the data.
Alternative Approach
We also developed an approach that did not rely on the AICc
and was thus independent of model complexity. Instead of
constraining the gamma or lognormal distributions to adopt
parameters consistent with a given paradigm and comparing
the fits we allowed the distributions to take up any parameter
combination, effectively allowing the distributions to vary across
the paradigms. For the gamma distribution there is a clear
mapping between the parameters of the distribution and the
paradigms (shape parameter = 1: age-independent distribution,
shape parameter < 1: risk paradigm, shape parameter > 1:
cyton paradigm). The lognormal distribution is less useful as it
cannot capture the age-independent paradigm and the mapping
between parameters and age-dependent paradigms is imprecise.
To investigate the best fitting lognormal distributions we plotted
the probability of an event conditioned on survival to that
point calculated from the best fit distribution (equations given
in Supplementary Information). For the risk paradigm the
distribution of the conditional probability would be expected to
be strongly left-skewed with a decreasing probability with age,
for the cyton paradigm there would be more weight to the right
with probabilities increasing with age. To illustrate the spread of
distributions we also plotted 100 trajectories created by sampling
the parameters from the normal distribution centered on the best
fit parameter with standard deviation the standard deviation of
the parameter estimate.
Heavy Water Data
Previously published in vivo heavy water labeling data from five
subjects were re-analyzed using the ABM (above). Experimental
details have been published elsewhere (32). Briefly, healthy young
adults (age 20–25) received heavy water for 9 weeks comprising
a prime of 10ml 2H2O/kg body weight over 24 h followed
by 1.25ml 2H2O/kg body weight daily. Cell samples were
taken at successive time points; urine samples were measured
for body water enrichment. Label enrichment in the DNA of
Naïve (CD45RO−CD27+) andMemory (CD45RO+), CD4+ and
CD8+ T cells were measured by GC-MS.
Deuterated Glucose and Annexin V+ Data
Four healthy adults (independent of the individuals studied
by heavy water labeling) were studied (age 21–33, median
24.5). Briefly, all received 6,6-2H2-glucose as a primed, 24 h
intravenous infusion. Cells dividing during the labeling phase
become labeled by incorporation of deuterium into their DNA.
Fifty milliliter of blood was taken at days 3, 4, 7, and 8;
PBMC were isolated by Ficoll gradient centrifugation and
CD3+CD4+CD45R0+ lymphocytes were separated within 4 h
of venepuncture by flow cytometry (Moflo flow cytometer,
Cytomation, Fort Collins, CO) according to Annexin V binding
into two populations: CD4+CD45RO+ Annexin V-bright and
CD4+CD45RO+ Annexin V-negative T cells; cells expressing
intermediate levels of Annexin-staining were not collected in this
analysis. Forward/side-scatter gating was used to exclude dead
cells and cellular debris. DNA was extracted and hydrolysed to
nucleosides and deuterium enrichment in DNA measured by
gas-chromatography mass-spectrometry as previously described
(5, 12) using the PCI derivative monitoring ions m/z 198 and 200
(Agilent GCMS, Agilent, Bracknell, UK).
The fractions of cells labeled and unlabeled at each time point
were quantified for both Annexin V-positive and –negative cell
populations for the 4 subjects. The fraction of Annexin V-positive
cells amongst labeled and unlabeled cells were derived from
those fractions as the ratio of the Annexin V-positive cells and
the sum of both Annexin V-positive and -negative populations
in labeled and unlabeled groups, respectively. This cannot be
measured directly i.e., we cannot sort labeled and unlabeled cells
and then quantify Annexin V expression as the measurement of
label requires the destruction of the cells (their DNA is isolated
and hydrolyzed).
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